Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Digital Therapeutic Company Pioneer My mHealth Announces Successful Roll-Out of NHS-Approved Diabetes App to the Community of Kent
My mhealth announces its successful roll-out of their NHS-approved diabetes digital therapeutic platform, myDiabetes, as […]
Research Presented at RDD 2021 Suggests That Acoustic Technology Is a Viable Alternative to High-cost Electronic Smart Inhalers
Research presented at the Respiratory Drug Delivery (RDD) 2021 conference suggests that inhalers using acoustic […]
Novavax Announces Positive Preclinical Data for Combination Influenza and COVID-19 Vaccine Candidate (NanoFlu/NVX-CoV2373)
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced […]
MATWIN Highlights Four Innovative Projects in the Fight Against Cancer
MATWIN, the French oncology accelerator and subsidiary of Unicancer, today announces the four winners chosen […]
BioNTech to Establish HQ for SE Asia in Singapore
BioNTech SE today announced plans to expand its global footprint to Asia with the establishment of […]
AI Consultation System PATCHS Could Slash GP Waiting Times
An AI online consultation system PATCHS could slash GP waiting times from three weeks to […]
Collective Health Secures $280 Million to Accelerate the Digital Transformation of Healthcare
Health technology company Collective Health today announced it secured $280 million in funding in a […]
Vida Health Raises $110m in Series D Round Led by General Atlantic, Centene, and Axa Venture Partners
Virtual chronic care platform Vida Health announced today that it raised $110M in its Series […]
Pfizer and BioNTech Initiate BLA for FDA Approval of Vaccine
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the initiation of a Biologics License Application […]
‘Never Done Before’ AI Study Could Improve Early Detection of Pancreatic Cancer
Artificial intelligence (AI) could potentially be used to aid early diagnosis of pancreatic cancer and […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more